Theranostics is a personalised cancer treatment combining diagnostics and therapies with an immense potential to transform the cancer care landscape. Enabled by molecular imaging techniques, theranostic approach uses specific targeting compounds for both imaging and therapy for a particular malignancy while sparing healthy tissues. As new molecular compounds are identified to target specific receptors, tissues, and tumour types, opportunities continue to expand for theranostic agents, invaluable for cancer patients.
AI is rapidly transforming theranostics, enhancing cancer diagnosis and treatment with precision and efficiency. By integrating AI, theranostics enables more accurate diagnoses and personalised therapies through data analysis and predictive modelling.
It also supports clinicians and patients in identifying new radiopharmaceutical targets and accelerating drug discovery. However, challenges like data security, accountability, and inclusivity hinder widespread adoption.
Further research and guidelines are needed to address these issues and fully realise AI's potential in clinical workflows. Perpetual is here to support your needs with our suite of services specific to theranostics, including leveraging AI for best practice.
Photo by UCLA Health
at: https://www.uclahealth.org/cancer/cancer-services/theranostics
Your healthcare, reimagined through innovation.